Abstract:
This invention relates to a method of producing an aqueous solution which comprises soluble benzene carboxylic acid salts which is substantially free of soluble humic acid salts. A first aqueous solution (22) which comprises soluble humic acid salts and soluble benzene carboxylic acid salts is reacted with carbon dioxide (32) and an inorganic chemical (34) selected from the group consisting of magnesium bicarbonate, magnesium carbonate, a double salt of magnesium carbonate, and mixtures thereof in a mixing zone (30) under conditions operable for converting the soluble humic acid salts to precipitated magnesium humic acid salts while maintaining the soluble benzene carboxylic acid salts in solution. The reacted first aqueous solution (36) is then separated in a separation zone (40) into (i) a second aqueous solution (44) which comprises the soluble benzene carboxylic acid salts and which is at least substantially free of soluble humic acid salts, and (ii) a mixture (42) which comprises precipitated magnesium humic acid salts.
Abstract:
This invention relates to a method of producing benzene carboxylic acids from an aromatic material, especially coal, by the oxidation of the aromatic material in an aqueous alkaline mixture containing an aliphatic organic acid promoter agent with a source of gaseous oxygen. Use of the aliphatic organic acid promoter agent results in a surprising and unexpected increase in the benzene carboxylic acid yield which is higher than that obtained without the promoter agent.A finely divided coal, potassium carbonate, water, and aliphatic carboxylic acid promoter agent are charged to a feed tank (10) where they are mixed with an agitator (14). A slurry pump (18) pumps the mixture through a preheater (20) to an autoclave (30). Air is continuously fed to the autoclave (30) by a gas compressor (34). The coal slurry is oxidized in the autoclave (30) while being agitated by a mixer (36). Gaseous products, and in particular carbon dioxide, is continuously removed from the autoclave (30) through a vent conduit (42). Benzene carboxylic acid salts produced in the autoclave (30) are removed and cooled in a cooler (52) and stored in a product tank (54).
Abstract:
A stratified bed of activated carbon having regions of functionalized and non-functionalized activated carbon can be utilized to remove contaminants from fluids such as groundwater. The functionalized region has activated carbon particles comprising a cationic or anionic compound that can remove organic or inorganic anionic or cationic compounds from the fluid to be treated. The non-functionalized region comprises powdered or granular activated carbon or adsorbent media downstream of the functionalized region and captures any leaching species or compounds from the functionalized region.
Abstract:
An activated carbon coated with an intumescent material which will expand at an elevated temperature and render the activated carbon resistant to oxidation. The activation carbon can be in granulated form, including pelletized, and impregnated. The intumescent material is preferably attached to about 10% of the exterior surface of the activated carbon and when exposed to a certain elevated temperature the intumescent material will expand and cover all or almost all of the exterior surface of the activated carbon thereby preventing its burning. The amount of intumescent material is not operable for causing a detrimental reduction in the adsorption capacity of the activated carbon when the coated activated carbon is at temperatures below the certain designed elevated temperature.
Abstract:
The invention relates to methods, reagents and apparatus for detecting protein isoforms (e.g., those due to alternative splicing, or different disease protein isoforms or degradation products) in a sample, including using combinations of capture agents, each combination being unique to the splicing variant to be detected/measured.
Abstract:
The present invention relates to methods and materials used to express an HBM-like polypeptide derived from HBM, LRP5 or LRP6 in animal cells and transgenic animals. The present invention also relates to transgenic animals expressing the HBM-like polypeptides. The invention provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development and lipid modulation. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
Abstract:
The invention relates to methods, reagents and apparatus for detecting protein isoforms (e.g., those due to alternative splicing, or different disease protein isoforms or degradation products) in a sample, including using combinations of capture agents to identify the isoforms to be detected/measured.